
This article aims at presenting the interest of high dose rate brachytherapy in the radiation treatment of prostatic adenocarcinoma. We will discuss successively the biological and dosimetric specificity of brachytherapy for this particular cancer. Afterwards, we will review the main phase II and III studies, the therapeutic indications in the daily practice from the evidence based medicine as well as the techniques of external beam radiation therapy for the same indications. Finally, the principal avenues of development will be discussed.
Male, Evidence-Based Medicine, Antineoplastic Agents, Hormonal, Radiotherapy Planning, Computer-Assisted, Brachytherapy, Prostatic Neoplasms, Radiotherapy Dosage, Adenocarcinoma, Combined Modality Therapy, Radiation Tolerance, Risk Assessment, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic, Humans, Radiation Injuries, Radiometry, Radiotherapy, Image-Guided, Ultrasonography
Male, Evidence-Based Medicine, Antineoplastic Agents, Hormonal, Radiotherapy Planning, Computer-Assisted, Brachytherapy, Prostatic Neoplasms, Radiotherapy Dosage, Adenocarcinoma, Combined Modality Therapy, Radiation Tolerance, Risk Assessment, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic, Humans, Radiation Injuries, Radiometry, Radiotherapy, Image-Guided, Ultrasonography
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 13 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
